Pharmaceutical companies’ concerns over ‘Financial Gain & Expenditure Report’ even before it starts

While being active in preparing for the ‘Financial Gain & Expenditure Report’ which will be implemented from 1 January 2018, pharmaceutical companies have encountered a new concern.

When the report became obligated, pharmaceutical companies were worried about the report itself, but they now have recently started to concern about when they actually have to store these reports. This is because t...